The Case for a Compliance-First Creative Brief
Most medical campaign disasters trace back to the same root cause: compliance was treated as a gate at the end, not an input at the start. Here is how to fix the brief.
The pattern repeats every quarter. A pharma brand invests six weeks in creative development, A/B test variants are shot and approved internally, media is booked — and then legal returns a redline that kills the hero claim. Two weeks of rework, the campaign launches three weeks late, and the media window is half gone.
The problem is structural, not accidental. Most agency briefs treat the compliance review as a step that happens after the creative is complete. That means every claim, every visual metaphor, and every CTA has been designed, iterated, and signed off internally before a single clinical reviewer has seen it.
Compliance as creative input.
A compliance-first brief moves the legal and medical review layer to the brief stage, not the approval stage. Before any concept is sketched, the team answers: What claims are substantiated? What level of evidence supports each one? What is the prescribing indication, and what is the approved label language? What competitor claims have already been challenged by regulators?
This sounds like it would slow things down. In practice it speeds things up, because it eliminates the late-stage redline cycle entirely. Creative teams stop investing effort in directions they will be forced to abandon.
What goes into the compliance section of a brief.
We recommend a dedicated block after the audience and objective sections: (1) Approved claims list — the exact language cleared by medical/legal/regulatory, (2) Off-limits territory — competitor claims under challenge, overpromised outcomes, unapproved indications, (3) Required disclosures — ISI placement, fair balance requirements for DTC, black-box warnings if applicable, (4) Channel-specific rules — different platforms have different enforcement postures for medical claims.
The practical rewrite.
When we run a brief audit for a new client, the first thing we look for is whether the document has a compliance block at all. More than 70% do not. Adding one does not require a legal degree — it requires a 30-minute call with the medical affairs or regulatory team to extract what they already know and document it in a format that creative teams can actually use.
The output is not a list of restrictions. It is a set of creative boundaries that, paradoxically, make the work faster and more confident. When a copywriter knows exactly which claims are defensible, they stop hedging everything and start writing with conviction.
If your last campaign launched late because of a compliance issue, the answer is almost never to get faster at legal review. The answer is to stop surprising your legal team.
Questions or pushback? Start a conversation.